{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:54:42Z","timestamp":1788818082500,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Shire Human Genetic Therapies, Inc"},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ymgmr.2017.10.011","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T16:17:50Z","timestamp":1514391470000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey"],"prefix":"10.1016","volume":"14","author":[{"given":"Ida Vanessa D.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"G\u00f6ker-Alpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Renault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Panahloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2017.10.011_bb0005","series-title":"Williams Hematology","article-title":"Gaucher disease and related lysosomal storage diseases","author":"Zimran","year":"2016"},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0015","first-page":"59","article-title":"Prevalence and management of Gaucher disease","volume":"2","author":"Burrow","year":"2011","journal-title":"Pediatr. Health Med. Ther."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0020","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00005-014-0308-8","article-title":"Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3","volume":"63","author":"Machaczka","year":"2015","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmhg.2011.02.008","article-title":"Outcome of enzyme replacement therapy in children with Gaucher disease: the Egyptian experience","volume":"12","author":"Khalifa","year":"2011","journal-title":"Egypt J. Med. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bcmd.2006.11.003","article-title":"Gaucher disease among Chinese patients: review on genotype\/phenotype correlation from 29 patients and identification of novel and rare alleles","volume":"38","author":"Choy","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bcmd.2010.07.010","article-title":"Clinical and genetic characteristics of Korean patients with Gaucher disease","volume":"46","author":"Jeong","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the international collaborative Gaucher group neurological outcomes subregistry","volume":"33","author":"Tylki-Szyma\u0144ska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1005495229655","article-title":"Enzyme replacement therapy in type III Gaucher disease","volume":"22","author":"Tylki-Szyma\u0144ska","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10545-013-9597-z","article-title":"Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience","volume":"36","author":"Tantawy","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.54.1.261","article-title":"Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC)","volume":"54","author":"Bohlega","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","article-title":"Management of neuronopathic Gaucher disease: revised recommendations","volume":"32","author":"Vellodi","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher's disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0090","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ymgme.2014.12.029","article-title":"Clinical characteristics of type III Gaucher disease in children and adolescents enrolled in a trial of velaglucerase alfa","volume":"114","author":"Ben Dridi","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0095","author":"European Medicines Agency"},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00431-012-1771-z","article-title":"Revised recommendations for the management of Gaucher disease in children","volume":"172","author":"Kaplan","year":"2013","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0105","author":"European Medicines Agency"},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0110","article-title":"Treatment patterns from 647 patients with Gaucher disease: an analysis from the Gaucher Outcome Survey","author":"Deegan","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0115","article-title":"Reported outcomes of 453 pregnancies in patients with Gaucher disease: an analysis from the Gaucher outcome survey","author":"Lau","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GIM.0b013e31818e2c19","article-title":"Dose-response relationships for enzyme replacement therapy with imiglucerase\/alglucerase in patients with Gaucher disease type 1","volume":"11","author":"Grabowski","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ymgme.2016.12.001","article-title":"Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the international collaborative Gaucher group Gaucher registry","volume":"120","author":"El-Beshlawy","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: a pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcmd.2016.02.003","article-title":"Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease","volume":"59","author":"Sonder","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0145","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1590\/S0100-879X2006000900004","article-title":"High frequency of mutation G377S in Brazilian type 3 Gaucher disease patients","volume":"39","author":"Rozenberg","year":"2006","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ymgmr.2017.10.011_bb0150","first-page":"683","article-title":"An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H","volume":"16","author":"Bronstein","year":"2014","journal-title":"Isr. Med. Assoc. J."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426917301416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426917301416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:49:38Z","timestamp":1762001378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426917301416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"alternative-id":["S2214426917301416"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2017.10.011","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}